Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Nielsen JC, Thomsen PE, Højberg S, Møller M, Riahi S, Dalsgaard D, Mortensen LS, Nielsen T, Asklund M, Friis EV, Christensen PD, Simonsen EH, Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR; DANPACE investigators. Nielsen JC, et al. Among authors: mortensen ls. Europace. 2012 May;14(5):682-9. doi: 10.1093/europace/eur365. Epub 2011 Nov 20. Europace. 2012. PMID: 22106360 Clinical Trial.
A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.
Nielsen JC, Thomsen PE, Højberg S, Møller M, Vesterlund T, Dalsgaard D, Mortensen LS, Nielsen T, Asklund M, Friis EV, Christensen PD, Simonsen EH, Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR; DANPACE Investigators. Nielsen JC, et al. Among authors: mortensen ls. Eur Heart J. 2011 Mar;32(6):686-96. doi: 10.1093/eurheartj/ehr022. Epub 2011 Feb 7. Eur Heart J. 2011. PMID: 21300730 Free article. Clinical Trial.
The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M, Walfridsson H, Janzon M, Walfridsson U, Nielsen JC, Hansen PS, Johannessen A, Raatikainen P, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Levin LÅ. Aronsson M, et al. Among authors: mortensen ls. Europace. 2015 Jan;17(1):48-55. doi: 10.1093/europace/euu188. Epub 2014 Oct 23. Europace. 2015. PMID: 25341739 Free article. Clinical Trial.
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation.
Jons C, Hansen PS, Johannessen A, Hindricks G, Raatikainen P, Kongstad O, Walfridsson H, Pehrson S, Almroth H, Hartikainen J, Petersen AK, Mortensen LS, Nielsen JC; MANTRA-PAF Investigators. Jons C, et al. Among authors: mortensen ls. Europace. 2009 Jul;11(7):917-23. doi: 10.1093/europace/eup122. Epub 2009 May 15. Europace. 2009. PMID: 19447807 Clinical Trial.
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
Madsen MM, Busk M, Søndergaard HM, Bøttcher M, Mortensen LS, Andersen HR, Nielsen TT; DANAMI-2 Investigators. Madsen MM, et al. Among authors: mortensen ls. Am J Cardiol. 2005 Dec 1;96(11):1469-75. doi: 10.1016/j.amjcard.2005.07.053. Epub 2005 Oct 11. Am J Cardiol. 2005. PMID: 16310424 Clinical Trial.
Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ, Hakalahti A, Uusimaa P, Nielsen JC, Johannessen A, Hindricks G, Walfridsson H, Pehrson S, Englund A, Hartikainen J, Kongstad O, Mortensen LS, Hansen PS; MANTRA-PAF investigators. Raatikainen MJ, et al. Among authors: mortensen ls. Int J Cardiol. 2015 Nov 1;198:108-14. doi: 10.1016/j.ijcard.2015.06.160. Epub 2015 Jul 4. Int J Cardiol. 2015. PMID: 26163901 Clinical Trial.
Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
Nielsen JC, Johannessen A, Raatikainen P, Hindricks G, Walfridsson H, Pehrson SM, Englund A, Hartikainen J, Mortensen LS, Hansen PS; MANTRA-PAF Investigators. Nielsen JC, et al. Among authors: mortensen ls. Heart. 2017 Mar;103(5):368-376. doi: 10.1136/heartjnl-2016-309781. Epub 2016 Aug 26. Heart. 2017. PMID: 27566295 Clinical Trial.
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
Walfridsson H, Walfridsson U, Nielsen JC, Johannessen A, Raatikainen P, Janzon M, Levin LA, Aronsson M, Hindricks G, Kongstad O, Pehrson S, Englund A, Hartikainen J, Mortensen LS, Hansen PS. Walfridsson H, et al. Among authors: mortensen ls. Europace. 2015 Feb;17(2):215-21. doi: 10.1093/europace/euu342. Epub 2015 Jan 6. Europace. 2015. PMID: 25567068 Clinical Trial.
124 results